Treatment for Severe Persistent Asthma

Introduction to Severe Asthma Management

• The American Academy of Family Physicians and the American Academy of Allergy, Asthma, and Immunology recommend high-dose inhaled corticosteroids combined with long-acting beta2-agonists as the foundation of treatment for severe persistent asthma, with the addition of oral systemic corticosteroids if needed to achieve and maintain control 1, 2

First-Line Therapy

• High-dose inhaled corticosteroids are the foundation of treatment for severe persistent asthma, providing the most effective anti-inflammatory action, as recommended by the American Academy of Allergy, Asthma, and Immunology 1, 3
• The American Academy of Allergy, Asthma, and Immunology suggests that long-acting beta2-agonists should be added to high-dose inhaled corticosteroids as standard combination therapy for severe persistent asthma 2, 4

Additional Medications When Control Is Not Achieved

• The American Academy of Allergy, Asthma, and Immunology recommends that oral systemic corticosteroids should be added (1-2 mg/kg/day, generally not exceeding 60 mg/day) when patients cannot achieve or maintain control with high-dose inhaled corticosteroids and long-acting beta2-agonists 2, 6

Quick-Relief Medications

• The American Academy of Family Physicians recommends that all patients with severe persistent asthma require short-acting beta2-agonists as needed for symptom relief 1, 7

Monitoring and Follow-Up

• The American Academy of Allergy, Asthma, and Immunology suggests that patients with severe persistent asthma should be monitored regularly for symptom control and medication side effects 3, 7
• The American Academy of Allergy, Asthma, and Immunology recommends that consultation with an asthma specialist is strongly recommended for patients with severe persistent asthma 6

Special Considerations

• The American Academy of Allergy, Asthma, and Immunology recommends that for children with severe persistent asthma, the approach is similar but with age-appropriate medication dosing 4, 8

Common Pitfalls to Avoid

• The American Academy of Family Physicians warns that using long-acting beta2-agonists as monotherapy without inhaled corticosteroids is contraindicated and can increase risk of severe exacerbations and death 5, 7